These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1294284)

  • 1. [A mathematical model of kinetic activation of blood coagulation factors VII and X].
    Khanin MA; Gorbatiuk IA
    Dokl Akad Nauk; 1992; 326(3):558-61. PubMed ID: 1294284
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathway. Kinetic behavior of two-chain factor VII in the presence and absence of tissue factor.
    Silverberg SA; Nemerson Y; Zur M
    J Biol Chem; 1977 Dec; 252(23):8481-8. PubMed ID: 925006
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of activated factor X in the control of bovine coagulation factor VII.
    Morrison-Silverberg SA; Jesty J
    J Biol Chem; 1981 Feb; 256(4):1625-30. PubMed ID: 7462215
    [No Abstract]   [Full Text] [Related]  

  • 4. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modification effect of the protein component of tissue thromboplastin (factor III) on its interaction with factors VII and X].
    Zubairov DM; Baĭkeev RF; Byshevskiĭ ASh; Tersenov OA
    Biokhimiia; 1984 Jun; 49(6):971-5. PubMed ID: 6466743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of depressive symptoms with coagulation factors in young healthy individuals.
    Doulalas AD; Rallidis LS; Gialernios T; Moschonas DN; Kougioulis MN; Rizos I; Tselegaridis TS; Kremastinos DT
    Atherosclerosis; 2006 May; 186(1):121-5. PubMed ID: 16076469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of factor V, VII and X activities, the key coagulant proteins of the tissue factor pathway in poultry plasma.
    Thomson AE; Squires EJ; Gentry PA
    Br Poult Sci; 2002 May; 43(2):313-21. PubMed ID: 12047098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor X and factor VII binding to endothelial protein C receptor differs between species.
    Puy C; Hermida J; Montes R
    J Thromb Haemost; 2011 Jun; 9(6):1255-7. PubMed ID: 21489130
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased activity of plasma clotting factors VII and X in acute ischemic cerebrovascular disease.
    Cîmpeanu E; Toma C; Bulboaca A; Roman S; Cucuianu M
    Neurol Psychiatr (Bucur); 1985; 23(3):163-8. PubMed ID: 4048804
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural genes of coagulation factors VII and X located on 13q34.
    Gilgenkrantz S; Briquel ME; André E; Alexandre P; Jalbert P; Le Marec B; Pouzol P; Pommereuil M
    Ann Genet; 1986; 29(1):32-5. PubMed ID: 3487272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological control of factor VII.
    Nemerson Y
    Thromb Haemost; 1976 Feb; 35(1):96-100. PubMed ID: 989197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of plasma lipid composition on activity of Factors V, VII and X in Single Comb White Leghorn and Fatty Liver Haemorrhagic Syndrome-susceptible laying hens.
    Yeh E; Wood RD; Squires EJ
    Br Poult Sci; 2008 Nov; 49(6):760-9. PubMed ID: 19093250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat.
    van Oosterom AT; Mattie H; Hermens WT; Veltkamp JJ
    Thromb Haemost; 1976 Jun; 35(3):607-19. PubMed ID: 989968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood coagulation system and fibrinolysis in patients with liver cirrhosis].
    Nielubowicz J; Lukasiewicz H
    Pol Przegl Chir; 1970 Oct; 42(10):1391-7. PubMed ID: 5495009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
    Mischke R
    Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The behavior of coagulation and fibrinolysis factors with different streptokinase doses].
    Poliwoda H; Krohn HP; Steuber H
    Med Lab (Stuttg); 1968 Nov; 21(11):252-61. PubMed ID: 5714595
    [No Abstract]   [Full Text] [Related]  

  • 18. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hemophilia B with a new clotting-factor concentrate.
    Hoag MS; Johnson FF; Robinson JA; Aggeler PM
    N Engl J Med; 1969 Mar; 280(11):581-6. PubMed ID: 5764825
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting the interaction of tissue factor/factor VII with factor X in a heterogeneous tubular reactor.
    Gemmell CH; Turitto VT; Nemerson Y
    Thromb Haemost; 1991 Feb; 65(2):139-43. PubMed ID: 2053099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.